Show simple item record

DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?

dc.contributor.authorOzdogan, H.
dc.contributor.authorUgurlu, S.
dc.contributor.authorOztas, M.
dc.contributor.authorSelvi, O.
dc.contributor.authorErgezen, B.
dc.date.accessioned2021-03-02T18:12:39Z
dc.date.available2021-03-02T18:12:39Z
dc.identifier.citationOztas M., Ugurlu S., Selvi O., Ergezen B., Ozdogan H., "DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?", Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.843
dc.identifier.othervv_1032021
dc.identifier.otherav_87fa672d-4b7c-4ffb-b563-a5184f3079df
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4690
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2020-eular.5625
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleDOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.identifier.volume79
dc.contributor.firstauthorID2282252


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record